Neurologian klinikka

Julkaisut 2012
Publications 2012

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Airas L, Kaaja R. Pregnancy and multilple sclerosis.
2 Alapirtti T et al. C-reactive protein and seizures in focal epilepsy: a video-electroencephalographic study.
3 Bhidayasiri R et al. Boxing and Parkinson disease: a link or a myth? An 18F-FDOPA PET/CT study in retired Thai traditional boxers.
4 Devonshire V et al. Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placeobo-controlled FREEDOMS study.
5 Ellfolk U et al. The effect of encoding condition on free recall in Parkinson's disease: incidental and intentional memory are equally affected.
6 Grimaldi L et al. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
7 Hankey GJ et al. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.
8 Hernandez DG et al. Genome wide assessment of young onset Parkinson's disease from Finland.
9 Jokela M et al. Double trouble: spinal muscular atrophy type II and seropositive myasthenia gravis in the same patient.
10 Joutsa J. Neurobiology of Pathological Gambling. Brain Imaging and Epidemiological Studies.
11 Joutsa J et al. Mesolimbic dopamine release is linked to symptom severity in pathological gambling.
12 Joutsa J et al. Parallel appearance of compulsive behaviours and artistic creativity in Parkinson's disease.
13 Joutsa J et al. Increased medial orbifrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders.
14 Joutsa J et al. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson´s disease.
15 Joutsa J et al. Impulse control disorders and depression in Finnish patients with Parkinson's disease.
16 Kaasinen V et al. Seasonality of striatal dopamine synthesis capacity in Parkinson's disease.
17 Keller MF et al. Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.
18 Kwon MS et al. No effects of short-term GSM mobile phone radiation on cerebral blood flow measured using positron emission tomography.
19 Linden S et al. Parechovirus infection preceding Guillan-Barré syndrome.
20 Martikainen MH et al. Progressive external ophthalmoplegia in southwestern Finland: a clinical and genetic study.
21 Martikainen MH et al. Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet.
22 Morrow DA et al. Vorapaxar in the secondary prevention of atherothrombotic events.
23 Olesen J et al. The economic cost of brain disorders in Europe.
24 Paavilainen T et al. Lower brain diffusivity in postpartum period compared to late pregnancy: results from a prospective imaging study of multiple sclerosis patients.
25 Puustinen J et al. CNS medications as predictors of precipitous cognitively disabled aged: A longitudinal population-based study.
26 Radue E-W et al. Impact of fingolimod therapy on magnetic resonance imaging outcomes in patients with multiple sclerosis.
27 Röyttä M et al. Hermosto ja lihakset.
28 Soilu-Hänninen M et al. A randomised, double-blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon B-1b in patients with multiple sclerosis .
29 Soinila S. National fibromyalgia questionnaires: Translated protocols or validated instruments?
30 Tallus J et al. Long-lasting TMS motor threshold elevation in mild traumatic brain injury.
31 Tenovuo O et al. International systems of care and research agendas .
32 Tuominen R et al. Treatment costs and productivity losses caused by traumatic brain injuries.
33 Virtanen I et al. Unenaikainen kohtauksellinen tukehtumisen tunne -diagnostinen haaste.
Julkaisutietokanta 3.9.2013 Publications Data Base 3.9.2013